Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform


Out of Business LATEST DEAL TYPE

Provider of cancer therapeutic devices and drugs for designed to revolutionize cancer treatments. The company's devices and drugs targets the the processes that normally stabilize the cancer cell and developing biomarkers to predict treatment response, enabling patients to get cancer treatments.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Therapeutic Devices
Primary Office
  • William Russell House
  • The Square, Surrey
  • Lightwater GU18 5SS
  • England, United Kingdom

+44 01276 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore TheRyte’s full profile, request a free trial.

TheRyte Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Oct-2016 00000 Completed Out of Business
4. Grant 14-Nov-2011 000.00 00000 Completed Generating Revenue
3. Later Stage VC 15-Sep-2011 00000 Completed Generating Revenue
2. Later Stage VC 10-Sep-2008 $455K $455K Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

TheRyte Executive Team (2)

Name Title Board
Hilmar Warenius Ph.D Co-Founder, Chief Medical Officer and Director of Research & Development

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »

TheRyte Board Members (4)

Name Representing Role Since Contact
Andrew Douglas TheRyte Board Member 000 0000
Nigel Rowbotham Self Board Member 000 0000

2 Former Board Members

You’re viewing 2 of 4 board members. Get the full list »